Description
The personalized medicine hypothesis was ranked highly but the debate did not identify which microbiome biomarkers or metabolomic profiles should guide therapeutic selection. This represents a critical gap for implementing precision gut-brain therapies.
Source: Debate session sess_sda-2026-04-01-003 (Analysis: sda-2026-04-01-003)